These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37139166)

  • 1. CC16 as an Inflammatory Biomarker in Induced Sputum Reflects Chronic Obstructive Pulmonary Disease (COPD) Severity.
    Chen M; Xu K; He Y; Jin J; Mao R; Gao L; Zhang Y; Wang G; Gao P; Xie M; Liu C; Chen Z
    Int J Chron Obstruct Pulmon Dis; 2023; 18():705-717. PubMed ID: 37139166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
    Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
    Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
    Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.
    Moermans C; Damas K; Guiot J; Njock MS; Corhay JL; Henket M; Schleich F; Louis R
    Cytokine; 2021 Apr; 140():155421. PubMed ID: 33486314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease and Contributes to the Diagnosis and Assessment of the Disease.
    Rong B; Fu T; Gao W; Li M; Rong C; Liu W; Liu H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():461-470. PubMed ID: 32184583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway inflammation contributes to health status in COPD: a cross-sectional study.
    Snoeck-Stroband JB; Postma DS; Lapperre TS; Gosman MM; Thiadens HA; Kauffman HF; Sont JK; Jansen DF; Sterk PJ
    Respir Res; 2006 Nov; 7(1):140. PubMed ID: 17137518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
    Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum ADAM8 expression is increased in severe asthma and COPD.
    Oreo KM; Gibson PG; Simpson JL; Wood LG; McDonald VM; Baines KJ
    Clin Exp Allergy; 2014 Mar; 44(3):342-52. PubMed ID: 24147597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
    Greulich T; Hohlfeld JM; Neuser P; Lueer K; Klemmer A; Schade-Brittinger C; Harnisch S; Garn H; Renz H; Homburg U; Renz J; Kirsten A; Pedersen F; Müller M; Vogelmeier CF; Watz H
    Respir Res; 2018 Apr; 19(1):55. PubMed ID: 29615049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
    Pignatti P; Visca D; Cherubino F; Zampogna E; Lucini E; Saderi L; Sotgiu G; Spanevello A
    Respir Res; 2019 Jul; 20(1):145. PubMed ID: 31291952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
    Hou C; Zhao H; Liu L; Li W; Zhou X; Lv Y; Shen X; Liang Z; Cai S; Zou F
    Mol Med; 2011; 17(7-8):807-15. PubMed ID: 21380479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway inflammation and mannitol challenge test in COPD.
    de Nijs SB; Fens N; Lutter R; Dijkers E; Krouwels FH; Smids-Dierdorp BS; van Steenwijk RP; Sterk PJ
    Respir Res; 2011 Jan; 12(1):11. PubMed ID: 21241520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum CC16 levels with eosinophilic inflammation and respiratory dysfunction in severe asthma.
    Goudarzi H; Kimura H; Kimura H; Makita H; Takimoto-Sato M; Abe Y; Oguma A; Matsumoto M; Takei N; Matsumoto-Sasaki M; Shimizu K; Suzuki M; Shijubo N; Huang SK; Hizawa N; Nishimura M; Konno S
    Respir Med; 2023 Jan; 206():107089. PubMed ID: 36542961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
    Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
    Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role for club cell secretory protein-16 (CC16) in the development of COPD.
    Laucho-Contreras ME; Polverino F; Gupta K; Taylor KL; Kelly E; Pinto-Plata V; Divo M; Ashfaq N; Petersen H; Stripp B; Pilon AL; Tesfaigzi Y; Celli BR; Owen CA
    Eur Respir J; 2015 Jun; 45(6):1544-56. PubMed ID: 25700379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of serum CC16 levels with smoking status and lung function in COPD.
    Gribben KC; Poole JA; Nelson AJ; Farazi PA; Wichman CS; Heires AJ; Romberger DJ; LeVan TD
    Respir Res; 2022 Sep; 23(1):247. PubMed ID: 36114505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.